China Pharma Holdings Inc - Company Profile

Powered by

All the sales intelligence you need on China Pharma Holdings Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how China Pharma Holdings Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with China Pharma Holdings Inc.

Back to companies

China Pharma Holdings Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

China Pharma Holdings Inc (China Pharma) develops, manufactures, and markets pharmaceutical products for human use, targeting high-incidence and high-mortality diseases. The company’s product portfolio includes dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The company offers western and traditional Chinese medicines in different therapeutic areas including central nervous system (CNS), cardiovascular, cerebrovascular, anti-viral, digestive diseases, infectious diseases, food supplements and others. China Pharma offers products in various dosage forms including lyophilized injectables, granules, tablets, capsules, injectables and oral fluids. It markets products in various provinces through sales offices across China. China Pharma is headquartered in Haikou, Hainan, China.

Gain a 360-degree view of China Pharma Holdings Inc and make more informed decisions for your business Gain a 360-degree view of China Pharma Holdings Inc and make more informed decisions for your business Learn more
Headquarters China

Address 2nd Floor, No. 17, Jinpan Road, Jiahai Building, Haikou, Hainan, 570216


Telephone 86 898 66811730

No of Employees 224

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange CPHI (AFM)

Revenue (2024) $4.5M -35.4% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ -53.8% (2024 vs 2023)

Market Cap* $29.1M

Net Profit Margin (2024) XYZ -138.2% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

China Pharma Holdings Inc premium industry data and analytics

16+

Marketed Drugs

Understand China Pharma Holdings Inc’s commercialized product portfolio to stay one step ahead of the market.

5

Clinical Trials

Determine China Pharma Holdings Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

Products and Services

Products Brands
Protective Ararato
KN95 Particulate Respirator Funalin
Disposable Medical Mask Fukexing
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand China Pharma Holdings Inc portfolio and identify potential areas for collaboration Understand China Pharma Holdings Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters China Pharma Holdings Inc Otsuka Holdings Co Ltd Chugai Pharmaceutical Co Ltd Shanghai Junshi Biosciences Co Ltd BrightGene Bio-Medical Technology Co Ltd
Headquarters China Japan Japan China China
City Haikou Minato Chuo-Ku Shanghai Suzhou
State/Province Hainan Tokyo Tokyo Shanghai Jiangsu
No. of Employees 224 35,338 7,778 2,670 1,151
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Zhilin Li Chairman; Chief Executive Officer; President Executive Board 2006 72
Baowen Dong Director Non Executive Board 2008 82
Heung Mei Tsui Director Non Executive Board 2009 68
Yingwen Zhang Director Non Executive Board 2008 81
Gene Michael Bennett Director Non Executive Board 2008 58
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into China Pharma Holdings Inc key executives to enhance your sales strategy Gain insight into China Pharma Holdings Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?